Founded in 2018, Buzzkill Labs has developed patented technologies for rapid, cost-effective detection of organic compounds. Buzzkill's proprietary oral fluid collection device combined with gold-standard chromatography-based analysis delivers the highest specificity and sensitivity on the market. Headquartered in Livermore, CA, Buzzkill capitalizes on the rich talent pool and startup-friendly environment of the Tri-Valley and San Francisco Bay Area.
Date | Amount | Type | Investors | Valuation |
---|---|---|---|---|
05/17/23 | undisclosed | Series A |
Poseidon | undisclosed |
05/17/23 | undisclosed | Series A |
Poseidon | undisclosed |